KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biolife Solutions (BLFS) Cash from Financing Activities (2016 - 2025)

Biolife Solutions (BLFS) has disclosed Cash from Financing Activities for 16 consecutive years, with -$2.5 million as the latest value for Q4 2025.

  • On a quarterly basis, Cash from Financing Activities rose 38.91% to -$2.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$10.9 million, a 61.05% decrease, with the full-year FY2025 number at -$10.9 million, down 61.05% from a year prior.
  • Cash from Financing Activities was -$2.5 million for Q4 2025 at Biolife Solutions, up from -$2.6 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $17.4 million in Q3 2022 to a low of -$4.1 million in Q4 2024.
  • A 5-year average of $321100.0 and a median of -$767500.0 in 2021 define the central range for Cash from Financing Activities.
  • Peak YoY movement for Cash from Financing Activities: skyrocketed 1745.65% in 2022, then crashed 308.81% in 2025.
  • Biolife Solutions' Cash from Financing Activities stood at -$2.1 million in 2021, then soared by 70.31% to -$625000.0 in 2022, then surged by 1674.56% to $9.8 million in 2023, then tumbled by 141.52% to -$4.1 million in 2024, then surged by 38.91% to -$2.5 million in 2025.
  • Per Business Quant, the three most recent readings for BLFS's Cash from Financing Activities are -$2.5 million (Q4 2025), -$2.6 million (Q3 2025), and -$2.9 million (Q2 2025).